Oncology
Conditions
Interventions
Rapid health technology assessment system of antineoplastic drugs (utilize the rapid health technology assessment system of antineoplastic drugs established by the study group in the temporary procure
Sponsors
Shanghai Sixth People’s Hospital
Eligibility
Sex/Gender
All
Age
22 Years to 99 Years
Inclusion criteria
Inclusion criteria: Since the study is designed to be a nationwide multi-center study, the preliminary plan is to include at least 1 each of tertiary general hospitals, oncology specialty hospitals, and combined traditional Chinese and Western medicine hospitals in each province and city, and at least 4 participating evaluators in each hospital, with the following specific criteria: 1. Inclusion criteria of medical institutions: ? able to administer novel anti-neoplastic drugs; ? tertiary hospital; ? general hospital, specialized oncology hospital, or combined Chinese and Western medicine hospital. 2. Inclusion criteria of evaluators: doctors, pharmacists, or medical administrative staff working in medical institutions that meet the above inclusion criteria.
Exclusion criteria
Exclusion criteria: Does not qualify for the inclusion criteria or unable to provide the consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| approval rate of temporary procurement application with rapid HTA score =60 ;change rate of temporary procurement application final decision before and after using the rapid HTA system;accuracy of the rapid HTA system;negative predictive value, NPV; | — |
Secondary
| Measure | Time frame |
|---|---|
| absolute difference of rapid HTA score among different sub-analysis groups;precision(positive predicative value, PPV) of the rapid HTA system;sensitivity of the rapic HTA system;F-measure; | — |
Countries
China
Contacts
Public ContactCheng Guo
Shanghai Sixth People’s Hospital
Outcome results
None listed